These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 15573900)

  • 21. [The present and future of levofloxacin in the treatment of respiratory infections].
    García-Rodríguez JA; Muñoz Bellido JL; Alonso Manzanares MA; Gutiérrez Zufiaurre MN
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():53-8. PubMed ID: 10563113
    [No Abstract]   [Full Text] [Related]  

  • 22. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
    Davis R; Bryson HM
    Drugs; 1994 Apr; 47(4):677-700. PubMed ID: 7516863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 24. [Levofloxacin: role and place in the treatment of infections of the lower respiratory tracts].
    Sinopal'nikov AI; Romanovskiĭ AG
    Ter Arkh; 2004; 76(11):51-6. PubMed ID: 15658538
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levofloxacin for the treatment of respiratory tract infections.
    Torres A; Liapikou A
    Expert Opin Pharmacother; 2012 Jun; 13(8):1203-12. PubMed ID: 22594848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PK/PD profile and post-marketing surveillance of levofloxacin].
    Pea F
    Infez Med; 2009 Dec; 17 Suppl 5():13-22. PubMed ID: 20424532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levofloxacin.
    Norrby SR
    Expert Opin Pharmacother; 1999 Nov; 1(1):109-19. PubMed ID: 11249554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Azithromycin (sumamed)--in the treatment of respiratory tract infections].
    Fomina IP; Smirnova LB; Iudin SM
    Antibiot Khimioter; 1996 Feb; 41(2):52-61. PubMed ID: 8929121
    [No Abstract]   [Full Text] [Related]  

  • 33. [Compliance in antibiotic therapy of respiratory tract infections].
    Karpov OI
    Antibiot Khimioter; 1999; 44(8):37-45. PubMed ID: 10494389
    [No Abstract]   [Full Text] [Related]  

  • 34. [Levofloxacin nowadays].
    Sidirenko SV
    Antibiot Khimioter; 2006; 51(1):28-37. PubMed ID: 16734363
    [No Abstract]   [Full Text] [Related]  

  • 35. Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'.
    Fish DN
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):371-87. PubMed ID: 15482135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [[New antimicrobial agent series XLVII]: levofloxacin].
    Saito A
    Jpn J Antibiot; 1994 Apr; 47(4):309-32. PubMed ID: 8201762
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical positioning of levofloxacin in the treatment of nosocomial pneumonia].
    Beloborodov VB
    Antibiot Khimioter; 2008; 53(9-10):12-20. PubMed ID: 19441645
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora.
    Acar JF
    Chemotherapy; 2001; 47 Suppl 3():15-23; discussion 44-8. PubMed ID: 11549785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Present aspects and prospects of levofloxacin use in therapy of nosocomial pneumonia].
    Riabkova EL; Kozlov RS
    Antibiot Khimioter; 2008; 53(9-10):6-11. PubMed ID: 19441644
    [No Abstract]   [Full Text] [Related]  

  • 40. Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.
    Keating GM
    Drugs; 2009 Jun; 69(9):1267-86. PubMed ID: 19537841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.